Tinostamustine Demonstrates Early Efficacy In Phase 1
19 Nov 2025 //
BUSINESSWIRE
FDA Grants Orphan Status To Tinostamustine For Malignant Glioma
10 Nov 2025 //
BUSINESS WIRE
Tinostamustine Included in GBM AGILE Trial for Glioblastoma
17 Sep 2025 //
BUSINESSWIRE
Purdue hires Ducharme as CSO to aid expansion beyond opioids
03 Jul 2019 //
FIERCE BIOTECH
Imbrium Announces USFDA Orphan Drug Designation for Tinostamustine
28 Mar 2019 //
BUSINESSWIRE

Market Place
Sourcing Support